Ramli I, Cheriet T, Posadino A, Giordo R, Fenu G, Chukwuemeka Nwachukwu K
EXCLI J. 2025; 23:1397-1439.
PMID: 39764218
PMC: 11701300.
DOI: 10.17179/excli2024-7791.
Falini B, Sorcini D, Perriello V, Sportoletti P
Leukemia. 2024; 39(2):276-290.
PMID: 39690184
DOI: 10.1038/s41375-024-02476-4.
Ryu S, Nakashima H, Tanaka Y, Mukai R, Ishihara Y, Tominaga T
Biomolecules. 2024; 14(8).
PMID: 39199272
PMC: 11351588.
DOI: 10.3390/biom14080885.
Lettin L, Erbay B, Blair G
Viruses. 2023; 15(12).
PMID: 38140552
PMC: 10747631.
DOI: 10.3390/v15122311.
Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R
Biology (Basel). 2023; 12(12).
PMID: 38132337
PMC: 10740672.
DOI: 10.3390/biology12121511.
Transcription factor E4F1 as a regulator of cell life and disease progression.
Sun S, Zhong B, Zeng X, Li J, Chen Q
Sci Adv. 2023; 9(39):eadh1991.
PMID: 37774036
PMC: 10541018.
DOI: 10.1126/sciadv.adh1991.
Tau protein binds to the P53 E3 ubiquitin ligase MDM2.
Sola M, Rendon-Angel A, Rojo Martinez V, Sgrignani J, Magrin C, Piovesana E
Sci Rep. 2023; 13(1):10208.
PMID: 37353565
PMC: 10290082.
DOI: 10.1038/s41598-023-37046-8.
A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma.
Liu A, Wang X, Hu L, Yan D, Yin Y, Zheng H
PLoS One. 2023; 18(6):e0287132.
PMID: 37352167
PMC: 10289466.
DOI: 10.1371/journal.pone.0287132.
MDM2 Implications for Potential Molecular Pathogenic Therapies of Soft-Tissue Tumors.
Sun S, Crago A
J Clin Med. 2023; 12(11).
PMID: 37297833
PMC: 10253559.
DOI: 10.3390/jcm12113638.
On the Roles of the Nuclear Non-Coding RNA-Dependent Membrane-Less Organelles in the Cellular Stress Response.
Gavrilova A, Fefilova A, Vishnyakov I, Kuznetsova I, Turoverov K, Uversky V
Int J Mol Sci. 2023; 24(9).
PMID: 37175815
PMC: 10179167.
DOI: 10.3390/ijms24098108.
Transformation of primary murine peritoneal mast cells by constitutive KIT activation is accompanied by loss of expression.
Capellmann S, Sonntag R, Schuler H, Meurer S, Gan L, Kauffmann M
Front Immunol. 2023; 14:1154416.
PMID: 37063827
PMC: 10097954.
DOI: 10.3389/fimmu.2023.1154416.
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex.
Huang X, Zhao Y, Wei M, Zhuge R, Zheng X
J Mol Cell Biol. 2023; 15(2).
PMID: 36881716
PMC: 10476552.
DOI: 10.1093/jmcb/mjad015.
Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H
Genes (Basel). 2023; 14(2).
PMID: 36833320
PMC: 9956157.
DOI: 10.3390/genes14020393.
The Underestimated Role of the p53 Pathway in Renal Cancer.
Amendolare A, Marzano F, Petruzzella V, Vacca R, Guerrini L, Pesole G
Cancers (Basel). 2022; 14(23).
PMID: 36497215
PMC: 9736171.
DOI: 10.3390/cancers14235733.
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.
Traweek R, Cope B, Roland C, Keung E, Nassif E, Erstad D
Front Oncol. 2022; 12:1006959.
PMID: 36439412
PMC: 9684653.
DOI: 10.3389/fonc.2022.1006959.
E3 ubiquitin ligases in the acute leukemic signaling pathways.
Zhan Q, Zhang H, Wu B, Zhang N, Zhang L
Front Physiol. 2022; 13:1004330.
PMID: 36439256
PMC: 9691902.
DOI: 10.3389/fphys.2022.1004330.
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z, Jin R, Zhang Y, Li H
Signal Transduct Target Ther. 2022; 7(1):353.
PMID: 36198685
PMC: 9535022.
DOI: 10.1038/s41392-022-01200-x.
Transcriptional regulation of INK4/ARF locus by cis and trans mechanisms.
Farooq U, Notani D
Front Cell Dev Biol. 2022; 10:948351.
PMID: 36158211
PMC: 9500187.
DOI: 10.3389/fcell.2022.948351.
The nucleolus is the site for inflammatory RNA decay during infection.
Lee T, Han H, Polash A, Cho S, Lee J, Ra E
Nat Commun. 2022; 13(1):5203.
PMID: 36057640
PMC: 9440930.
DOI: 10.1038/s41467-022-32856-2.
Cyclin-dependent kinase inhibitors in malignant hematopoiesis.
Schirripa A, Sexl V, Kollmann K
Front Oncol. 2022; 12:916682.
PMID: 36033505
PMC: 9403899.
DOI: 10.3389/fonc.2022.916682.